1
|
Marijam A, Safonova E, Scherbakov M, Shpeer E, Van Oorschot D, Rudakova A, Tatochenko V, Briko N. Cost effectiveness and budget impact of universal varicella vaccination in Russia. Hum Vaccin Immunother 2022; 18:2045152. [PMID: 35258445 PMCID: PMC9196720 DOI: 10.1080/21645515.2022.2045152] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
This economic evaluation assesses the cost-effectiveness and budget impact of introducing a two-dose varicella vaccine in the Russian national immunization program. A static Markov model followed a simulated 2019 Russian cohort over its lifetime and compared outcomes and costs of three varicella vaccination strategies: strategy I (doses given at 12 and 15 months of age), strategy II (doses given at 1 year and 6 years of age), and a no vaccination scenario. Inputs on age-dependent clinical pathways, associated costs, and related health outcomes were collected from national sources and published literature. Results are presented as incremental cost-effectiveness ratio (ICER) from the healthcare payer and societal perspective over the lifetime of the birth cohort and the budget impact over a 10 years' time horizon. Vaccination strategies I and II resulted in an ICER of approximately 1.7 million rubles per quality-adjusted life years gained from the healthcare payer perspective and were cost-saving from the societal perspective. From the healthcare payer perspective, the costs per varicella case averted were 5,989 and 7,140 rubles per case for strategies I and II, respectively. However, from the societal perspective, vaccination is a dominant strategy and the budget impact analysis shows significant healthcare savings over 10 years, with strategy I realizing savings of ~2 billion rubles more than strategy II. From a public health impact perspective, varicella vaccination of children at 12 and 15 months of age through the Russian NIP is expected to be cost-effective with an affordable budget impact compared to no vaccination.
Collapse
Affiliation(s)
| | | | | | | | | | - Alla Rudakova
- Pediatric Research and Clinical Center for Infectious Diseases, Saint Petersburg, Russia
| | | | - Nikolay Briko
- Sechenov First Moscow State Medical University of The Ministry of Health of the Russian Federation, Moscow, Russia
| |
Collapse
|
2
|
Betsch C, Bach Habersaat K, Deshevoi S, Heinemeier D, Briko N, Kostenko N, Kocik J, Böhm R, Zettler I, Wiysonge CS, Dubé È, Gagneur A, Botelho-Nevers E, Gagneux-Brunon A, Sivelä J. Sample study protocol for adapting and translating the 5C scale to assess the psychological antecedents of vaccination. BMJ Open 2020; 10:e034869. [PMID: 32161160 PMCID: PMC7066639 DOI: 10.1136/bmjopen-2019-034869] [Citation(s) in RCA: 50] [Impact Index Per Article: 12.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
INTRODUCTION Published in 2018, the 5C scale is psychometrically validated to assess five psychological antecedents of vaccination (confidence, complacency, constraints, calculation and collective responsibility). The original version offers a validated English and German scale to assess these determinants with a short 5-item scale (1 item per antecedent) and a long 15-item scale (3 items per antecedent). This sample study protocol provides a step-by-step guidance for the process of adapting the 5C scale to another country, language or cultural context. Data obtained from the 5C scale can support developing, implementing and evaluating an intervention and monitoring of general vaccine acceptance and demand. METHODS AND ANALYSIS Phase 1 comprises the adaptation of the 5C scale including the translation and back translation of the antecedents, an expert evaluation of the antecedents and the identification of new antecedents as well as a pretest. Phase 2 involves the validation of the translated and potentially expanded scale including the assessment of reliability, construct and concurrent validity of all items of the scale. Code for data analysis is provided. ETHICS AND DISSEMINATION The University of Erfurt's institutional review board provided ethical clearance (EV-201900416.2). The authors suggest and encourage publicly sharing all data obtained from the translated 5C scale (eg, on publication). The materials and the code for data analysis to support the process described in this protocol are available in https://osf.io/2agxe/. Sharing data on vaccine acceptance and demand is in the public and the scientific interest and will facilitate gaining a global overview of its current state and development over time. The authors of the original 5C scale are currently working on an online platform to facilitate publishing the data and to visualise the psychological antecedents across different countries.
Collapse
Affiliation(s)
- Cornelia Betsch
- Center for Empirical Research in Economics and Behavioral Sciences (CEREB), University Erfurt, Erfurt, Thüringen, Germany
- Media and Communication Science, University Erfurt, Erfurt, Thüringen, Germany
| | - Katrine Bach Habersaat
- Vaccine-preventable Diseases and Immunization (VPI), Division of Health Emergencies and Communicable Diseases (DEC), World Health Organization Regional Office for Europe, DK-2100 Copenhagen, Denmark
| | - Sergei Deshevoi
- Vaccine-preventable Diseases & Immunization (VPI), Division of Communicable Diseases & Health Security (DCH), World Health Organization Regional Office for Europe, Copenhagen, Denmark
| | - Dorothee Heinemeier
- Center for Empirical Research in Economics and Behavioral Sciences (CEREB), University Erfurt, Erfurt, Thüringen, Germany
- Media and Communication Science, University Erfurt, Erfurt, Thüringen, Germany
| | - Nikolay Briko
- Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, 119991 Moscow, Russian Federation
| | - Natalia Kostenko
- Ministry of Health of the Russian Federation, 127051 Moscow, Russian Federation
| | - Janusz Kocik
- School of Public Health, Center of Postgraduate Medical Education, Medical University of Warsaw, Warsaw, Poland
| | - Robert Böhm
- Department of Psychology, University of Copenhagen, Copenhagen, Denmark
| | - Ingo Zettler
- Department of Psychology, University of Copenhagen, Copenhagen, Denmark
| | - Charles Shey Wiysonge
- Cochrane South Africa, South African Medical Research Council, Tygerberg, South Africa
| | - Ève Dubé
- CHU de Québec-Université Laval, Quebec City, Quebec, Canada
| | - Arnaud Gagneur
- Département de Pédiatrie, Unité de Néonatalogie, CHUS Fleurimont, Universite de Sherbrooke, Sherbrooke, Quebec, Canada
| | - Elisabeth Botelho-Nevers
- Service d'Infectiologie, CIC-1408 INSERM Vaccinologie, Centre Hospitalier Universitaire de Saint-Étienne, Saint-Etienne, Rhône-Alpes, France
| | - Amandine Gagneux-Brunon
- Service d'Infectiologie, CIC-1408 INSERM Vaccinologie, Centre Hospitalier Universitaire de Saint-Étienne, Saint-Etienne, Auvergne-Rhône-Alpes, France
| | - Jonas Sivelä
- Department of Health Security, Finnish Institute for Health and Welfare, Helsinki, Uusimaa, Finland
| |
Collapse
|
3
|
Sidorenko S, Rennert W, Lobzin Y, Briko N, Kozlov R, Namazova-Baranova L, Tsvetkova I, Ageevets V, Nikitina E, Ardysheva A, Bikmieva A, Bolgarova E, Volkova M, Verentsova I, Girina A, Gordeeva N, Demko I, Dushchenko A, Evseeva G, Zharkova L, Yelistratova T, Zakharova J, Ivakhnishina N, Zubova E, Kalinogorskaya O, Klimashina A, Kozeeva T, Kraposhina A, Krechikova O, Mamaeva M, Nagovitsyna E, Protasova I, Semerikov V, Sokolova N, Soloveva I, Strelnikova N, Telepneva R, Feldblium I, Kholodok G, Chagaryan A, Sheglinkova N. Multicenter study of serotype distribution of Streptococcus pneumoniae nasopharyngeal isolates from healthy children in the Russian Federation after introduction of PCV13 into the National Vaccination Calendar. Diagn Microbiol Infect Dis 2019; 96:114914. [PMID: 31704066 DOI: 10.1016/j.diagmicrobio.2019.114914] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2019] [Revised: 09/13/2019] [Accepted: 09/22/2019] [Indexed: 10/25/2022]
Abstract
Russia introduced PCV13 in 2014. We studied the serotype composition of S. pneumoniae isolated from the nasopharynx of healthy children younger than 6 years in St. Petersburg, Smolensk, Perm, Krasnoyarsk, Khanty-Mansiysk and Khabarovsk, between 2016 and 2018. 2.4% of children had completed a 3-dose course of PCV13, while 25.6% had received 1 or 2 doses. Pneumococcal DNA detection by PCR demonstrated S. pneumoniae in 37.2% of samples with regional variation between sites (27.3 to 56.9%). There was little difference between vaccinated, partially vaccinated and un-vaccinated children. Children who had received at least 1 dose of PCV13 had lower carriage rates of vaccine serotypes than their unvaccinated peers (49.9 vs. 61.4%; p < 0.001). Children who had received at least 1 dose of PCV13 showed increased carriage rates of non-vaccine serotypes (50 vs 38.6%; P < 0.001). Especially serogroup 15AF was more prevalent among fully immunized children than among their peers (12.5 vs 2.7%; P < 0.05).
Collapse
Affiliation(s)
- Sergey Sidorenko
- Pediatric Research and Clinical Center for Infectious Diseases, Popov Str.9, Saint Petersburg, Russia, 197022 and North Western State Medical University named after I.I. Mechnikov, Kirochnaya Str. 41, St Petersburg, Russia, 191015.
| | - Wolfgang Rennert
- Rostropovich Vishnevskaya Foundation and Georgetown University Hospital Department of Pediatrics, 4200 Wisconsin Ave. # 200, Washington, DC, 20016, USA.
| | - Yuri Lobzin
- Pediatric Research and Clinical Center for Infectious Diseases, Popov Str.9, Saint Petersburg, Russia, 197022 and North Western State Medical University named after I.I. Mechnikov, Kirochnaya Str. 41, St Petersburg, Russia, 191015.
| | - Nikolay Briko
- I.M. Sechenov First Moscow State Medical University, Trubetskaya Str. 8-2, Moscow, Russia, 119991.
| | - Roman Kozlov
- Smolensk State Medical University, Krupskoy Str. 28, Smolensk, Russia 214019.
| | - Leila Namazova-Baranova
- Pirogov Russian National Research Medical University, Ostrovityanova Str. 1, Moskva, Russia, 11799.
| | - Irina Tsvetkova
- Pediatric Research and Clinical Center for Infectious Diseases, Professor Popov Str.9, Saint Petersburg, Russia, 197022.
| | - Vladimir Ageevets
- Pediatric Research and Clinical Center for Infectious Diseases, Professor Popov Str.9, Saint Petersburg, Russia, 197022.
| | - Ekaterina Nikitina
- Pediatric Research and Clinical Center for Infectious Diseases, Professor Popov Str.9, Saint Petersburg, Russia, 198022.
| | - Anastasia Ardysheva
- Perm Clinical Center of the Federal Medical and Biological Agency, Tselinnaya Str., 27, Perm, Russia, 614056.
| | - Alina Bikmieva
- E.A.Vagner Perm State Medical University, 26 Petropavlovskaya Str, Perm, Russia 614990.
| | - Ekaterina Bolgarova
- Yekaterinburg Research Institute of Viral Infections, Letnyaya Str 23, Yekaterinburg, Russia 620030.
| | - Marina Volkova
- Pediatric Research and Clinical Center for Infectious Diseases, Professor Popov Str.9, Saint Petersburg, Russia, 197022.
| | - Irina Verentsova
- Regional Clinical Hospital, Kalinina Str. 40, Khanty-Mansiysk, Russia 628012.
| | - Asiya Girina
- Khanty-Mansiysk State Medical Academy, Mira Str. 40. Khanty-Mansyisk, Russia 628011.
| | - Natalia Gordeeva
- Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Partizana Zheleznyaka Str. 1, Krasnoyarsk, Russia 660022.
| | - Irina Demko
- Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Partizana Zheleznyaka Str. 1, Krasnoyarsk, Russia 660022.
| | - Anna Dushchenko
- Far Eastern State Medical University, Karl Marx Str. 35, Khabarovsk, Russia 680000.
| | - Galina Evseeva
- Khabarovsk Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration, - Research Institute of Maternity and Childhood Protection, Voronezhskaya Str. 49, Khabarovsk, Russia 680022.
| | - Ludmila Zharkova
- Smolensk State Medical University, Krupskoy Str. 28, Smolensk, Russia 214019.
| | - Tatyana Yelistratova
- Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Partizana Zheleznyaka Str. 1, Krasnoyarsk, Russia 660022.
| | - Julia Zakharova
- Yekaterinburg Research Institute of Viral Infections, Letnyaya Str 23, Yekaterinburg, Russia 620030.
| | - Natalia Ivakhnishina
- Khabarovsk Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration, - Research Institute of Maternity and Childhood Protection, Voronezhskaya Str. 49, Khabarovsk, Russia 680022.
| | - Elena Zubova
- Regional Pediatric Hospital, Baumana Str 22, Perm, Russia 614066.
| | - Olga Kalinogorskaya
- Pediatric Research and Clinical Center for Infectious Diseases, Professor Popov Str. 9, Saint Petersburg, Russia, 194100.
| | - Alla Klimashina
- Perm Clinical Center of the Federal Medical and Biological Agency, Tselinnaya Str., 27, Perm, Russia, 614056.
| | - Tatiana Kozeeva
- Perm Clinical Center of the Federal Medical and Biological Agency, Tselinnaya Str., 27, Perm, Russia, 614056.
| | - Angelina Kraposhina
- Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Partizana Zheleznyaka Str. 1, Krasnoyarsk, Russia 660022.
| | - Olga Krechikova
- Smolensk State Medical University, Krupskoy Str. 28, Smolensk, Russia 214019.
| | - Marina Mamaeva
- Krasnoyarsk State Medical University named after Professor V. F. Voino-Yasenetsky, Partizana Zheleznyaka Str. 1, Krasnoyarsk, Russia 660022.
| | - Elena Nagovitsyna
- Khabarovsk Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration, - Research Institute of Maternity and Childhood Protection, Voronezhskaya Str. 49, Khabarovsk, Russia 680022.
| | - Irina Protasova
- Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Partizana Zheleznyaka Str. 1, Krasnoyarsk, Russia 660022.
| | | | - Natalia Sokolova
- Perm Clinical Center of the Federal Medical and Biological Agency, Tselinnaya Str., 27, Perm, Russia, 614056.
| | - Irina Soloveva
- Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Partizana Zheleznyaka Str. 1, Krasnoyarsk, Russia 660022.
| | - Natalia Strelnikova
- Far Eastern State Medical University, Karl Marx Str. 35, Khabarovsk, Russia 680000.
| | - Regina Telepneva
- Khabarovsk Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration, - Research Institute of Maternity and Childhood Protection, Voronezhskaya Str. 49, Khabarovsk, Russia 680022.
| | - Irina Feldblium
- E.A.Vagner Perm State Medical University, Petropavlovskaya Str. 26, Perm, Russia 614990.
| | - Galina Kholodok
- Khabarovsk Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration, - Research Institute of Maternity and Childhood Protection, Voronezhskaya Str. 49, Khabarovsk, Russia 680022.
| | - Aida Chagaryan
- Smolensk State Medical University, Krupskoy Str. 28, Smolensk, Russia 214019.
| | | |
Collapse
|